Last reviewed · How we verify

NCT04651114

Pilot Testing a New Pregnancy Decision Making Tool for Women With Physical Disabilities

Completed NA Results posted Last updated 14 July 2022
What this trial tests

NA trial testing Decision-making tool in Disability Physical in 38 participants. Completed in 14 May 2021.

Timeline
11 December 2020
Primary endpoint
14 May 2021
14 May 2021

Quick facts

Lead sponsorUniversity of Michigan
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment38
Start date11 December 2020
Primary completion14 May 2021
Estimated completion14 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Michigan

Who can join

18 and older, female only, with Disability Physical. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Final Decisional Conflict Scale Score - Values Clarity Sub-scale Primary · 12 weeks

The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Values Clarity sub-scale refers to how much a respondent is clear about the values that guide their decision-making. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater clarity of values.

GroupValue95% CI
Decision-making Tool13.1± 2.3
Final Decisional Conflict Scale Score - Support Sub-scale Primary · 12 weeks

The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Support for Decision Making sub-scale refers to how much support a respondent has from others about their decision-making. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater support for decision-making.

GroupValue95% CI
Decision-making Tool12.6± 2.1
Final Decisional Conflict Scale Score - Uncertainty Sub-scale Primary · 12 weeks

The Decisional Conflict Scale is a self-report measure. Decisional conflict refers to a state of uncertainty about a course of action. For this study, this refers to uncertainty about pursuing a future pregnancy. The Uncertainty about the decision sub-scale refers to how much a respondent is uncertain about the decision. Sub-scale items (3) are rated on 5-point Likert scales (ranging from strongly agree \[5\] to strongly disagree \[1\]) and summed for a total score range of 3 to 15. Higher scores represent greater certainty about the decision.

GroupValue95% CI
Decision-making Tool11.3± 2.9
Final Readiness to Make a Choice in Stage of Decision-Making Scale Primary · 12 weeks

The Stage of Decision Making is a single item self-report measure. The options range from "haven't begun to think about choices" to "have already made a decision and unlikely to change my mind". The instructions were modified to refer to pregnancy and excluded the first two options of not having begun to think about choices given inclusion criteria. For this study, the scale ranged from 1 (are considering the decision now) to 4 (have already made a decision and am unlikely to change my mind). A higher score reflects greater readiness to make a decision.

GroupValue95% CI
Decision-making Tool3.1± 1.0
Feasibility - Acceptability Secondary · 12 weeks

Acceptability of decision making tool is refers to whether the intervention is agreeable or satisfactory. In this study we measured this by self-report. We used 11 items that measured the presentation of information of the tool rated on Likert scales ranging from 1 (poor) to 4 (excellent) which are summed across all items. Possible scores can range from 11 to 44, with higher scores reflecting better information presentation.

GroupValue95% CI
Decision-making Tool35.7± 6.4
Feasibility - Demand Secondary · 12 weeks

Demand refers to the likelihood of using an intervention after the study is over. For this study, it is a single item rated on Likert scales of 1 (definitely not likely) to 5 (very likely). Higher scores indicate a higher likelihood of using the tool after the study is over.

GroupValue95% CI
Decision-making Tool4± 1.3
Feasibility - Ease of Use Secondary · 12 weeks

Ease of use refers to how easy an intervention is to use. In this study, we measures ease of use of the tool with a self-report, single item rated on Likert scales ranging from 1 (very hard) to 5 (very easy). A higher rating means the tool was considered easier to use.

GroupValue95% CI
Decision-making Tool4.5± 1.2

Sponsor's own description

The purpose of this project is to develop, and pilot test a decision-making tool that is tailored for women with physical disabilities to support those women in making a decision about whether or not a pregnancy is right given the participant's situation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Development and pilot test of a pregnancy decision making tool for women with physical disabilities.
    Kalpakjian CZ, Haapala HJ, Ernst SD, Orians BR, et al · · 2023 · cited 4× · PMID 36401816 · DOI 10.1111/1475-6773.14103

Verify or expand the search:

Other trials of Decision-making tool

Trials testing the same drug.

Other recruiting trials for Disability Physical

Currently open trials in the same condition.

Other University of Michigan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04651114.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing